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Abstract Brief exposure of endothelial cells to oxidative stress
induced by hypoxia followed by reoxygenation enhances tube
formation. Our study provides evidence that hypoxic precondi-
tioning accelerates tubular morphogenesis along with the
activation of reactive oxygen species-inducible nuclear transcrip-
tion factor-UB (NF-UB), phosphatidylinositol 3-kinase (PI3-
kinase) and broad-spectrum anti-apoptotic protein survivin in
human coronary arteriolar endothelial cells (HCAEC). The
formation of tubular morphogenesis was inhibited by using the
PI3-kinase and NF-UB antagonists LY294002 and SN50
respectively. The activation of survivin by hypoxic precondition-
ing was also inhibited by LY294002 and SN50 along with
increased apoptosis in HCAEC. These data demonstrate a
crucial role of PI3-kinase/Akt/NF-UB/survivin signaling in
tubular morphogenesis of HCAEC triggered by hypoxic
preconditioning. ß 2001 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
Angiogenesis is regulated and controlled by several known
and as yet unknown factors. It is an important process in
in£ammation, solid tumor growth and several other patholog-
ical phenomena. Short exposure to hypoxia/reoxygenation,
either directly or indirectly, produces oxidative stress which
is associated with angiogenesis or neovascularization. This
process is thought to be regulated by several growth factors
(epidermal, transforming-K, L-¢broblast, vascular endothelial
(VEGF)). Induction of angiogenic factors is triggered by var-
ious stresses. For instance, tissue hypoxia exerts its pro-angio-
genic action through various angiogenic factors, the most no-
table being VEGF, which has been mainly associated with
initiating the process of angiogenesis through the recruitment
and proliferation of endothelial cells.
Mechanisms controlling angiogenesis and tubular morpho-
genesis in rat myocardium and human microvascular endothe-
lial cells respectively by nuclear transcription factor NF-UB
are well-established [1^4]. NF-UB appears to be a critical reg-
ulator for gene expression induced by diverse stress signals
including mutagenic, oxidative and hypoxic stresses [3,4]. Ac-
tivation of NF-UB is likely to be involved in the induction of
gene expression associated with ischemic as well as hypoxic
adaptation [5]. NF-UB is present as a predominant form in
unstimulated cells as a heterodimer of two proteins, p50 and
p65 complexed to an inhibitory subunit called IUB that pre-
vents migration of the heterodimer to the nucleus and DNA
binding. Under stress, this inhibitory subunit becomes phos-
phorylated and dissociated from NF-UB, allowing migration
of the heterodimer to the nucleus where it binds to DNA and
increases gene transcription [6]. Recently, phosphorylation of
IUB-K by phosphatidylinositol 3-kinase (PI3-kinase) was dem-
onstrated which directly caused the release of IUB-K from the
NF-UB complex [7]. A recent study documented that myocar-
dial adaptation to ischemia by repeated brief episodes of is-
chemia and reperfusion translocated and activated the DNA
binding capacity of NF-UB [8]. NF-UB is an oxidative stress
responsive transcription factor and plays a signi¢cant role in
the process of apoptosis [9]. This nuclear transcription factor
appears to function both as a pro- and as an anti-apoptotic
factor depending upon cell type and mode of stress [10].
Survivin, a recently described inhibitor of apoptosis, also
plays a signi¢cant role in the process of cell proliferation in
human hepatocellular carcinoma [11]. It was demonstrated
that angiopoietin-1 (Ang-1), presumably acting via the Tie-2
tyrosine kinase receptor, is capable of preventing endothelial
cell apoptosis by activating Akt, a critical survival messenger.
In addition, Ang-1 also can up-regulate the broad-spectrum
apoptosis inhibitor, survivin [12]. Thus, inhibition of endothe-
lial cell apoptosis by survivin expression may have signi¢cant
clinical signi¢cance in the realm of angiogenesis by improving
endothelial cell viability.
This study was undertaken to investigate the role of survi-
vin in angiogenesis and the signi¢cance of the inhibition of
apoptosis during this process. This study utilized human cor-
onary arteriolar endothelial cells (HCAEC) as an in vitro
angiogenesis model to examine the e¡ect of hypoxic precon-
ditioning on cell migration or tubular morphogenesis, survivin
expression and the extent of apoptosis. The involvement of
transcription factor NF-UB and PI3-kinase was also examined
to establish the molecular mechanism of the expression of
survivin and their role in the process of tubular morphogen-
esis by increasing endothelial cell viability. In this study, we
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demonstrate for the ¢rst time the involvement of NF-UB and
PI3-kinase in the upregulation of the expression of the anti-
apoptotic protein survivin with concomitant increase in the
HCAEC viability and tubular morphogenesis by hypoxic pre-
conditioning.
2. Materials and methods
2.1. Endothelial cell culture
HCAEC were obtained from BioWhittaker (Walkersville, MD,
USA) and they were serially passaged. Cells were maintained in a
culture medium, EGM-2.
2.2. Hypoxia/reoxygenation
Con£uent HCAEC were plated on plastic 100 mm dishes supple-
mented with cell medium, pH 6.7 and subjected to di¡erent durations
of hypoxia (4, 6 and 8 h) in an air-tight chamber under constant
nitrogen atmosphere for the respective durations, pre-gassed with
95% N2^5% CO2, pO2 level 6 32 mm Hg. After the respective dura-
tion of hypoxia cells were exposed to reoxygenation for 24 h. HCAEC
maintained under normoxic conditions at pO2 160 mm Hg served as
controls. To determine whether SN50 (NF-UB inhibitor obtained from
Calbiochem, San Diego, CA, USA) and LY294002 (PI3-kinase inhib-
itor obtained from Sigma, St. Louis, MO, USA) have any e¡ect on
the expression of survivin or the extent of apoptosis and tubular
morphogenesis, cells were incubated with 18 WM SN50 (8) and 5 WM
LY294002 [13] for 1 h prior to induction of hypoxia.
2.3. Qualitative analysis of tube formation by HCAEC
The endothelial cells (5U104) were seeded onto Matrigel (Becton
Dickinson Labware, Bedford, MA, USA) in a culture slide chamber
with four wells. The chambers with the cells were exposed to hypoxia
and reoxygenation in a closed incubator as discussed above. The cells
were exposed to SN50 and LY294002 before even hypoxic exposure.
After various durations of hypoxia followed by 18 h of reoxygenation
the reorganization of the HCAEC and the extent of tube formation
was recorded by phase contrast microscope (magni¢cation U200)
with a digital camera.
2.4. Detection of apoptosis-induced DNA strand breaks using terminal
deoxynucleotidyl transferase (TdT)-mediated dUTP nick end
labeling (TUNEL)
Coronary arteriolar endothelial cells, after exposure to various ex-
perimental protocols in situ, were ¢xed in 3.7% formaldehyde solution
(pH 7.4). We used the Fragment End Labeling (FragEL1, Oncogene
Research Products, Cambridge, MA, USA) DNA fragmentation de-
tection kit to detect apoptosis. In this assay terminal deoxynucleotidyl
transferase (TdT) binds to expose 3P-OH ends of DNA fragments
generated in response to apoptotic signals and catalyze the addition
of biotin-labeled and unlabeled deoxynucleotides. Biotinylated nucleo-
tides are detected using a streptavidin^horseradish peroxidase (HRP)
conjugate. Diaminobenzidine reacts with the labeled sample to gen-
erate an insoluble colored substrate at the site of DNA fragmentation.
Counterstaining with methyl green aids in the morphological evalua-
tion and characterization of normal and apoptotic cells.
2.5. Nuclear extract preparation for gel shift assay
Endothelial cells were washed with ice-cold phosphate-bu¡ered sa-
line, scraped from the plates and suspended in bu¡er A (10 mM
HEPES [N-2-hydroxyethylpiperazine-NP-2-ethanesulfonic acid, pH
7.9], 10 mM KCl, 0.1 mM EDTA [ethylenediaminetetraacetic acid],
0.1 mM EGTA [ethylene glycol-bis(2-amino-ethyl ether)-N,N,NP,NP-
tetraacetic acid], 1 mM DTT [dithiothreitol], and 0.5 mM PMSF
[phenylmethylsulfonyl £uoride]). The cells were allowed to swell on
ice for 15 min, then Nonidet P-40 was added to a ¢nal concentration
of 0.5%. After centrifugation, the pellet was washed with bu¡er A.
The nuclear pellet was resuspended in ice-cold bu¡er C (20 mM
HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM
PMSF, 1 mM DTT, 1 Wg/ml of pepstatin, 1 Wg/ml of leupeptin) and
allowed to swell on ice for 1 h. The nuclear extract was obtained after
centrifugation at 12 000Ug for 20 min. The supernatant was kept at
370‡C for further use [8].
Protein concentration was estimated as above. NF-UB oligonucleo-
tide (AGTTGAGGGGACTTTCCCAGG) (2.5 Wl, 20 ng/Wl) was la-
beled using T4 polynucleotide kinase as previously described. The
binding reaction mixture contained in a total volume of 20.2 Wl, 0.2
Wl DTT (0.2 M), 1Wl BSA (bovine serum albumin, 20 mg/ml), 4 Wl
poly(dI-dC) (0.5 Wg/Wl), 2 Wl bu¡er D, 4 Wl bu¡er F, 2 Wl [32P]oligo
(0.5 ng/Wl) and 7 Wl extract containing 10 Wg protein. Composition of
bu¡er D was 20 mM HEPES, pH 7.9, 20% glycerol, 100 mM KCl,
0.5 mM EDTA, 0.25% Nonidet P-40 while bu¡er F contained 20%
Ficoll 400, 100 mM HEPES, pH 7.9, and 300 mM KCl. Incubation
was carried out for 20 min at room temperature. 10 Wl of the solution
was loaded onto a 4% acrylamide gel and separated at 80 V until the
dye hit the bottom. After electrophoresis, gels were dried and exposed
to Kodak X-ray ¢lm at 370‡C.
The purity of the nuclear extracts was examined using lactate de-
hydrogenase as a cytosolic marker. The supershift assays and the
competition assays were performed to measure that the signal was
speci¢c for NF-UB. For the assays, anti-p65 or anti-p50 antibodies
were added, separately or together, to the reaction mixtures immedi-
ately after addition of radiolabeled probe. For the competition assays,
increasing fold molar excess of unlabelled NF-UB oligonucleotide was
added into separate reaction mixtures.
2.6. Western blot analysis for survivin
For immunodetection of survivin, endothelial cells after various
experimental protocols were harvested in lysis bu¡er (1.0% Igepal
CA.630, 0.5% sodium deoxycholate, 0.1% SDS [sodium dodecyl sul-
fate]). Pure cell lysates obtained after centrifugation were used for
protein analysis. Total protein concentrations were determined using
the bicinchoninic acid protein assay kit (Pierce, Rockville, IL, USA).
Cell lysates (40 Wg) were run on polyacrylamide electrophoretic gels
(SDS^PAGE) typically using 15% (acrylamide to bisacrylamide ratio).
Separated proteins were electrophoretically transferred to polyvinyli-
dene di£uoride membrane (Millipore, Bedford, MA, USA) using a
semidry transfer system (Bio-Rad, Hercules, CA, USA). Protein stan-
dards (Bio-Rad) were run in each gel. The blots were blocked in Tris-
bu¡ered saline/Tween-20 (TBS-T containing 20 mM Tris base, pH
7.6, 137 mM NaCl, 0.1% Tween-20) supplemented with 5% BSA for
1 h. Blots were incubated for 2 h with the speci¢c primary rabbit
antibodies (Novus Biologicals, Littleton, CO, USA) against survivin
(1:1000). Blots were then incubated for 1 h at room temperature with
1:4500 diluted HRP-conjugated secondary antibodies (Boehringer
Mannheim, Indianapolis, IN, USA) which were goat anti-rabbit
IgG. Direct reprobing with anti-L-actin antibody as an internal con-
trol for Western blot was also performed. The blot was directly re-
probed after washing with PBS-T for 10 min at room temperature,
and then reprobed with a mouse monoclonal anti-L-actin as an inter-
nal control antibody (clone AC-150; Sigma, St. Louis, MO, USA)
with a dilution of 1:5000 in blocking solution after detection of the
primary target. The secondary antibody used for L-actin was HRP-
conjugated goat polyclonal anti-mouse IgG (Transduction Laborato-
ries, Lexington, KY, USA). After three washes of 5 min each, blots
were treated with Enhanced Chemiluminescence reagent (ECL from
Amersham, Life Science, Arlington Heights, IL, USA) and the re-
quired proteins were detected by autoradiography for variable lengths
of time with Kodak X-Omat ¢lm. All the samples were tested for non-
speci¢c labeling. Negative and positive controls were run to validate
the results.
2.7. Measurement of malonaldehyde (MDA) formation by HPLC
The cells were exposed to various durations of hypoxia and reox-
ygenation; the cells were harvested, washed with PBS containing so-
dium metabisul¢te at 4‡C, counted and weighed. The cell pellets were
immediately homogenized by a Brinkman Polytron (Westbury, NY,
USA) in 2 ml 10% TCA (trichloroacetic acid) containing 5.9 mM
sodium metabisul¢te, vortexed on ice for 10 min and centrifuged at
3000Ug for 10 min at 4‡C. TCA supernatants were immediately de-
rivatized with 100 Wl 2,4-dinitrophenylhydrazine (3.1 mg/ml 2 N HCl),
and then extracted with pentane. MDA formation was then measured
using HPLC [14].
2.8. Statistical analysis
Data were obtained from at least six independent cell cultures. For
statistical analysis, a two-way analysis of variance (ANOVA) followed
by Sche¡e¤’s test was ¢rst carried out using Primer Computer Program
(McGraw-Hill, 1988) to test for any di¡erences between groups. If
di¡erences were established, the values were compared using Student’s
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t-test. The values are expressed as mean þ S.E.M. The results were
considered signi¢cant if P6 0.05.
3. Results
3.1. Tubular morphogenesis of HCAEC after hypoxic
preconditioning: e¡ect of SN50 and LY294002
HCAEC plated on the surface of Matrigel after 4, 6 and 8 h
of hypoxia followed by reoxygenation form tube-like struc-
tures. The formation of a capillary network of tubular struc-
ture was extremely prominent when the cells were exposed to
8 h of hypoxia followed by 12 h of reoxygenation (Fig. 1D vs.
Fig. 1B,C). Modulation of the NF-UB- and PI3-kinase-depen-
dent angiogenesis in the system was examined with SN50 (18
WM) and LY294002 (5 WM), inhibitors of NF-UB and PI3-
kinase, respectively. The cells were pre-incubated with either
SN50 or LY294002 and then were exposed to hypoxia and
reoxygenation. Cells pretreated with SN50 and LY294002 dis-
played inhibition of hypoxia/reoxygenation-mediated tubular
morphogenesis of HCAEC (Fig. 1E,F). NF-UB and PI3-ki-
nase appeared to be directly involved in hypoxia/reoxygena-
tion-mediated HCAEC tubular morphogenesis.
3.2. Activation of the DNA binding activity of NF-UB during
hypoxic preconditioning
The binding activity of NF-UB increased signi¢cantly when
Fig. 1. Development of tube-like structures by HCAEC. Cells were plated onto Matrigel when they were con£uent. A: Baseline control, nor-
moxic. B: Cells exposed to 4 h hypoxia followed by 12 h of reoxygenation. C: Cells exposed to 6 h hypoxia followed by 12 h reoxygenation.
D: Cells exposed to 8 h of hypoxia followed by 12 h of hypoxia. E: Cells pretreated with NF-UB inhibitor SN50 followed by 8 h of hypoxia
and 12 h of reoxygenation. F: Cells pretreated with PI3-kinase inhibitor LY94002 followed by 8 h hypoxia and 12 h of reoxygenation. Note
the inhibition of tube formation by SN50 and LY294002. The tube formation is very prominent when the cells were exposed to 8 h of hypoxia
followed by 12 h of reoxygenation.
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the cells were exposed to hypoxia and reoxygenation (Fig. 2B^
D). The DNA binding activity was increased by 35% after 4 h
of hypoxic insult and 45% after 6 h hypoxia compared to the
baseline control. The 8 h hypoxic cells (Fig. 2D) showed a
66% increase in the DNA binding activity of NF-UB when
compared to the normoxic, baseline control endothelial cells.
This increased DNA activity of NF-UB was signi¢cantly de-
creased when SN50 and LY294002, inhibitors of NF-UB and
PI3-kinase, respectively, were used (as shown in Fig. 2E,F).
To con¢rm NF-UB binding activity with p65, we performed
supershift assay with a polyclonal antibody recognizing NF-
UB p65 subunit proteins as shown in lanes G and H of Fig. 2.
3.3. Activation of the expression of the anti-apoptotic protein
survivin during hypoxic preconditioning
Western blot analysis revealed a prominent 16.5 kDa survi-
vin band which was signi¢cantly induced in HCAEC exposed
to hypoxia/reoxygenation (Fig. 3). Survivin was found to be
increased by 25% after 4 h of hypoxia whereas this broad-
spectrum anti-apoptotic protein was increased 5.1- and 7.4-
fold in 6 h and 8 h hypoxic cells, respectively, when compared
to the control baseline values. However, treatment with SN50
as well as LY294002 reduced the induction of survivin signi¢-
cantly (Fig. 3E,F) and restored the baseline level. This clearly
establishes the involvement of NF-UB and PI3-kinase in the
regulation of expression of the anti-death protein survivin.
3.4. Hypoxic preconditioning-mediated oxidative stress as
measured by MDA
Oxygen-derived free radicals play a crucial role in the path-
ophysiology of reoxygenation-mediated injury and hypoxia/
reoxygenation causes the development of oxidative stress to
HCAEC. MDA production is a presumptive marker for the
development of oxidative stress. As depicted in Fig. 4, the
MDA concentration in HCAEC was increased from
196.7 þ 34.3 to 350 þ 63.1 pmol/g after 4 h of hypoxia followed
by 2 h reoxygenation. The level of oxidative stress as mea-
sured by the concentration of MDA formation was signi¢-
cantly reduced to 93.1 þ 9.3 and 100 þ 10 pmol/g. These values
were reduced below the baseline values when the duration of
hypoxia was increased to either 6 or 8 h, followed by 2 h
reoxygenation (Fig. 4). The amount of oxidative stress was
signi¢cantly increased, as expected, in SN50- and LY294002-
treated cells even after 8 h of hypoxia followed by 2 h reox-
ygenation (390 þ 22 and 412 þ 25 pmol/g). This demonstrates
that NF-UB and PI3-kinase inhibition increases oxidative
stress and thereby increases the extent of apoptosis.
3.5. The extent of apoptosis during hypoxic preconditioning
As expected, the extent of apoptosis increased with increas-
ing oxidative stress as observed by the enhanced MDA pro-
duction in the hypoxic cells. HCAEC exposed to 4 h hypoxia
followed by 2 h reoxygenation (23.7 þ 2.5% vs. 5.3 þ 1.8%)
Fig. 2. E¡ect of various durations of hypoxia followed by 2 h of reoxygenation on the DNA binding activity of NF-UB. Lane A: Control base-
line. Lane B: Cells exposed to 4 h hypoxia followed by 2 h of reoxygenation. Lane C: 6 h hypoxia followed by 2 h of reoxygenation. Lane D:
8 h of hypoxia followed by 2 h of reoxygenation. Lane E: cells pretreated with SN50 followed by 8 h of hypoxia and 2 h of reoxygenation.
Lane F: Cells pretreated with LY294002 followed by 8 h of hypoxia and 2 h of reoxygenation. Lanes G and H: Baseline samples were used to
perform supershift assay with a polyclonal antibody recognising NFkB p65 subunit proteins.
Fig. 3. Western blot analysis for survivin expression. Lane A: Control baseline. Lane B: Cells exposed to 4 h hypoxia followed by 24 h of re-
oxygenation. Lane C: 6 h hypoxia followed by 24 h of reoxygenation. Lane D: 8 h of hypoxia followed by 24 h of reoxygenation. Lane E:
Cells pretreated with SN50 followed by 8 h of hypoxia and 24 h of reoxygenation. Lane F: Cells pretreated with LY294002 followed by 8 h of
hypoxia and 24 h of reoxygenation.
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revealed a signi¢cant number of apoptotic cells compared to
baseline control. However, when the hypoxic period was in-
creased to 6 h or 8 h followed by the same 2 h of reoxygena-
tion, the number of apoptotic cells was decreased to baseline
(6 þ 2% and 7.2 þ 1.9 vs. 5.3 þ 0.8%) control value (Fig. 5). On
the other hand, the number of apoptotic cells was signi¢cantly
increased with the treatment of SN50 and LY294002
(40.5 þ 3% and 42.5 þ 4%, respectively).
4. Discussion
In this study, we have demonstrated the activation and
regulation of survivin, an anti-apoptotic protein, during
HCAEC survival and tubular morphogenesis induced by hy-
poxic preconditioning. These ¢ndings constitute, to the best of
our knowledge, the ¢rst direct demonstration of the role of
PI3-kinase and NF-UB in regulating the anti-death candidate,
survivin. The results clearly demonstrated the involvement of
NF-UB and PI3-kinase as essential components of the survivin
signaling pathway. Recent experimental evidence has sug-
gested that regulation of endothelial cell apoptosis may be
an essential mechanism to maintain angiogenesis in vivo
[15]. This is also documented in our experimental ¢nding
that during SN50 and LY294002 treatment (Fig. 1E,F) a sig-
ni¢cant increase in cell apoptosis was observed which was
accompanied by a decrease in tubular morphogenesis. There-
fore, a direct relationship does exist between endothelial cell
apoptosis and tubular morphogenesis. In this model, survivin,
a recently described crucial regulator in the molecular mech-
anism of apoptosis, played a signi¢cant role in the reduction
of cell apoptosis. Survivin is the smallest member of the IAP
gene family. It is expressed in several apoptosis-regulated fetal
tissues, including lung, liver, heart, and gastrointestinal tract
[11]. Activation of survivin was found to inhibit caspase-3
activity [16]. Therefore inhibition of endothelial cell apoptosis
during angiogenesis may occur simultaneously through vari-
ous pathways, which might involve mitochondrial integrity by
bcl-2 [17] and suppression of caspase activity by survivin
[18,19].
Interestingly, our results indicate that hypoxic precondition-
ing induced adaptive modi¢cation of the arteriolar endothelial
cells by oxidative stress where reactive oxygen species play a
role as signaling molecules and thereby are able to reduce
cellular injury. The lipid peroxidation product MDA is a pre-
sumptive marker for oxidative stress and an indicator of free
radical production. As shown in our study, 4, 6 and 8 h of
hypoxia followed by 2 h reoxygenation resulted in the devel-
opment of short-lived oxidative stress. This stress increased
appreciably after 4 h hypoxia followed by 2 h of reoxygena-
tion and then came down steadily and progressively. It is
interesting to note that after 6 and 8 h of hypoxia followed
by 2 h of reoxygenation, the MDA level was decreased to
below the baseline value. Corroborating these ¢ndings, the
up-regulation of the anti-death candidate survivin increased
to 5.1- and 7.5-fold of the baseline control. Therefore, it is
tempting to speculate that such up-regulation of survivin fol-
lowed by reduced apoptosis may have resulted from adapta-
tion of the HCAEC to the oxidative stress. The event of adap-
tation required almost 24 h in our experimental model. In
addition, it is also possible that some other stress proteins
are being activated in response to hypoxic stress and mediate
the bene¢cial e¡ects of hypoxia/reoxygenation.
Another interesting ¢nding was the inhibition of DNA
binding activity of NF-UB by the PI3-kinase inhibitor
LY294002, in HCAEC. This was accompanied by severe oxi-
dative stress as documented by increased MDA production
and activation of apoptosis. It was suggested that both the
regulatory and the catalytic subunits of PI3-kinase play a role
in NF-UB activation by the tyrosine phosphorylation-depen-
dent pathway [20]. The function of PI3-kinase in NF-UB acti-
vation may also involve its phosphorylated lipid products.
These lipid mediators may regulate the activity of protein ki-
nases, e.g. PKCj [21]. This isoform has already been impli-
cated in NF-UB activation [22]. Recent studies have also in-
dicated that PKCj is a downstream target of PI3-kinase in
vivo. Here we showed that the PI3-kinase antagonist
LY294002 and the NF-UB antagonist SN50 act cooperatively
to inhibit hypoxia/reoxygenation-mediated HCAEC survival.
This suggests the importance of the PI3-kinase/Akt pathway
Fig. 4. E¡ects of various durations of hypoxia/reoxygenation on
MDA content of HCAEC. A: Control baseline. B: Cells exposed to
4 h hypoxia followed by 2 h of reoxygenation. C: 6 h hypoxia fol-
lowed by 2 h of reoxygenation. D: 8 h of hypoxia followed by 2 h
of reoxygenation. E: Cells pretreated with SN50 followed by 8 h of
hypoxia and 2 h of reoxygenation. F: Cells pretreated with
LY294002 followed by 8 h of hypoxia and 2 h of reoxygenation.
MDA was estimated in cells using HPLC as described in Section 2.
Results are mean þ S.E.M. of six di¡erent sets. Each result was run
in duplicate. *P6 0.05 compared to control.
Fig. 5. Evaluation of endothelial apoptosis using TUNEL staining.
Bar graph showing average number of endothelial cells undergoing
apoptosis. Results are expressed as mean þ S.E.M. of six di¡erent
sets. A: Control baseline. B: Cells exposed to 4 h hypoxia followed
by 2 h of reoxygenation. C: 6 h hypoxia followed by 2 h of reoxy-
genation. D: 8 h of hypoxia followed by 2 h of reoxygenation. E:
Cells pretreated with SN50 followed by 8 h of hypoxia and 2 h of
reoxygenation. F: Cells pretreated with LY294002 followed by 8 h
of hypoxia and 2 h of reoxygenation. *P6 0.05 compared to con-
trol.
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along with NF-UB in survival signaling. Several lines of evi-
dence exist to indicate the involvement of Ang-1 and VEGF
in the activation of the survival-promoting PI3-kinase/Akt
pathway in promoting survival signal [23^26]. One of the po-
tential targets of PI3-kinase is the serine/threonine kinase,
Akt. Activation of Akt triggers survival signaling that even-
tually inhibits apoptosis. The pro-apoptotic factor Bad was
recently found to be phosphorylated by activated Akt. Phos-
phorylation of Bad dissociates from Bcl-xl. Released Bcl-xl
thus promotes cell survival. Recently, Akt was also found to
phosphorylate caspase-9 and thereby diminishes its activity.
Therefore the PI3-kinase pathway may promote cell survival
and angiogenesis. It may control survival and death by vari-
ous multiple downstream mechanisms. Thus, one of the multi-
ple downstream mechanisms for survival signaling may be
PI3-kinase^Akt^NF-UB^survivin.
In conclusion, we have demonstrated the role of PI3-kinase
in cooperation with the redox-regulated transcription factor
NF-UB in hypoxic preconditioning-mediated HCAEC tubular
morphogenesis. Also, activation of this pathway decreases cell
death through the induction of the broad-spectrum anti-apo-
ptotic protein survivin.
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